In patients with combined type 2 diabetes and CAD, FGF-23 independently predicts adverse cardiovascular outcome [7] and, additionally, elevated FGF-23 concentrations following acute coronary syndrome are associated with an increased risk of CV death and hospitalization due to heart failure [8]. Here, FGF23 is linked to coronary artery disorder.